About Neocardial Technologies

About company

NeoCardial Technologies™, LLC, is an early-stage medical device company, founded to innovate and offer improved treatment options and results for underserved patients suffering from late stage heart failure. NeoCardial’s first product for commercialization, the eHeart™, is a non-blood contact, direct compression, extra-ventricular circulatory support device. Implanted using a thoracotomy procedure, the eHeart™ provides immediate cardiac output assistance to a failing heart. The eHeart™ minimizes the complications associated with Ventricular Assist Devices including surgical complications and the complications caused by direct blood contact. eHeart™ reduces complications while providing a dynamic means of sustaining circulation and physiological parameters that current and prior products have been unable to deliver. Unique to the eHeart™ is an innovative approach to addressing these issues.